跳至主要内容
临床试验/JPRN-UMIN000004408
JPRN-UMIN000004408已完成4 期

Examination of the efficacy and safety of Doripenem for hospital-aquired pneumonia - Examination of the efficacy and safety of Doripenem

Hamamatsu University0 个研究点目标入组 80 人开始时间: 2010年11月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patient who corresponds to either the following excludes it from the object of the examination 1:Patient who is administering valproate sodium 2:Patient who has the past of shock or hypersensitivity for this medicine 3:Patient with liver dysfunction AST(GOT):100IU/L or more, ALT(GTP):100IU/L or more 4:Patient who has disease of central nervous system or with the past of epilepsy 5:Patient who has allergy or serious side effect in betalactam system medicine 6:Patient who has been put in to examination once 7:Patient who participated in other clinical trials and clinical researches within four months in the past 8:Patient who needs using prohibition medicine 9:patient whom conducting of the examination doctor judged that pursuit of right evaluation and enough passage is impossible 10:Pediatrics 11:Patient who corresponds to PS4

研究者

发起方
Hamamatsu University

相似试验